Study Examining PrEP-001 in Healthy Subjects
NCT03220048
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza A H3N2
Interventions
DRUG:
PrEP-001
OTHER:
Placebo Comparator
Sponsor
Hvivo
Collaborators
[object Object]